Diagnostics body drafts in Edelman

Medical diagnostic companies are stepping up their profile among policy makers to stress their importance in helping to deliver the Government’s pledge to cut ‘hidden waiting lists’.

The British In Vitro Diagnostics Association (BIVDA) – the trade body for manufacturers and distributors of diagnostics equipment – has appointed Edelman's PA and corporate teams to the task after a competitive pitch. The move follows Labour's promise to cut NHS waiting times to a maximum of 18 weeks from GP referral for treatment by 2008, which will require test results to be speeded up.

BIVDA represents firms involved in testing of conditions such as diabetes, hepatitis and HIV. Its members include Roche and Bayer.

BIVDA director-general Doris-Ann Williams said: 'From modernisation of pathology services to reduction in waiting times, the Government will look increasingly to diagnostic services.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in